Huping Song1, Lili Wang, Yannian Hui. 1. Department of Ophthalmology, Xijing Hospital, Fourth Military Medical University and Eye Institute of PLA, Xian 710032, People's Republic of China. songhpxian@163.com
Abstract
AIM: To investigate the expression of CD18 on neutrophils from patients with various stages of diabetic retinopathy (DR) and to determine the possibility of using it as a marker of disease development. RESEARCH DESIGN AND METHODS: Levels of CD18 on neutrophils were measured by flow cytometry in 10 patients with DR stage 1, 14 patients in stages 2-4, 14 patients in stage 5 and 10 non-diabetic healthy subjects (control). RESULTS: Mean channel fluorescence (MCF) of CD18 on neutrophils from the control, stage 1, stages 2-4 and stage 5 groups were 1.36+/-0.17, 2.99+/-1.44, 3.13+/-1.10 and 4.11+/-1.62, respectively. The difference among them was significant (P=0.00). The highest was from the stage 5 group, then stages 2-4 and stage 1. The least was from the control group (trend test, P=0.00). This trend remained after adjusting for confounding variables. This trend was only significant in type 2 when subjects were divided according to diabetic type, even after adjusting for confounding factors. Multiple linear regression against the level of CD18 MCF by stage of DR and covariates revealed a significant and independent association with the stage of DR (beta=0.33; P=0.01). CONCLUSION: Elevated levels of CD18 on neutrophils were present in each stage of DR in type 2 diabetic patients. The more severe the disease, the higher the level was. CD18 may be a marker of the development of DR in type 2 diabetes.
AIM: To investigate the expression of CD18 on neutrophils from patients with various stages of diabetic retinopathy (DR) and to determine the possibility of using it as a marker of disease development. RESEARCH DESIGN AND METHODS: Levels of CD18 on neutrophils were measured by flow cytometry in 10 patients with DR stage 1, 14 patients in stages 2-4, 14 patients in stage 5 and 10 non-diabetic healthy subjects (control). RESULTS: Mean channel fluorescence (MCF) of CD18 on neutrophils from the control, stage 1, stages 2-4 and stage 5 groups were 1.36+/-0.17, 2.99+/-1.44, 3.13+/-1.10 and 4.11+/-1.62, respectively. The difference among them was significant (P=0.00). The highest was from the stage 5 group, then stages 2-4 and stage 1. The least was from the control group (trend test, P=0.00). This trend remained after adjusting for confounding variables. This trend was only significant in type 2 when subjects were divided according to diabetic type, even after adjusting for confounding factors. Multiple linear regression against the level of CD18 MCF by stage of DR and covariates revealed a significant and independent association with the stage of DR (beta=0.33; P=0.01). CONCLUSION: Elevated levels of CD18 on neutrophils were present in each stage of DR in type 2 diabeticpatients. The more severe the disease, the higher the level was. CD18 may be a marker of the development of DR in type 2 diabetes.
Authors: C W Park; J H Kim; J H Lee; Y S Kim; H J Ahn; Y S Shin; S Y Kim; E J Choi; Y S Chang; B K Bang; J W Lee Journal: Diabetologia Date: 2000-12 Impact factor: 10.122
Authors: M Morigi; S Angioletti; B Imberti; R Donadelli; G Micheletti; M Figliuzzi; A Remuzzi; C Zoja; G Remuzzi Journal: J Clin Invest Date: 1998-05-01 Impact factor: 14.808
Authors: K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis Journal: Proc Natl Acad Sci U S A Date: 1999-09-14 Impact factor: 11.205
Authors: C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer Journal: Ophthalmology Date: 2003-09 Impact factor: 12.079
Authors: Ioannis K Petropoulos; Panagiotis I Margetis; Marianna H Antonelou; John X Koliopoulos; Sotirios P Gartaganis; Lukas H Margaritis; Issidora S Papassideri Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-08 Impact factor: 3.535
Authors: Michael A Grassi; Vidhya R Rao; Siquan Chen; Dingcai Cao; Xiaoyu Gao; Patricia A Cleary; R Stephanie Huang; Andrew D Paterson; Rama Natarajan; Jalees Rehman; Timothy S Kern Journal: PLoS One Date: 2016-08-10 Impact factor: 3.240